EX-23.1 4 brhc10026159_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
 
We consent to the use of our report dated March 2, 2021, with respect to the consolidated financial statements of Antares Pharma, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the registration statement.
 
 
Minneapolis, MN
 
June 24, 2021